Navigation Links
OXYMATIC® 401 Electronic Oxygen Conserver

ProductsOXYMATIC® 401 Electronic Oxygen Conserver
Company CHAD Therapeutics, Inc.
Item OXYMATIC® 401 Electronic Oxygen Conserver
Features 
  • Alternate Breath Delivery with Built-In Brass Regulator (Continuous flow preset at 2 lpm)
  • Weighs approximately 1.8 lbs (816 grams) with the battery
  • Provides every-breath or alternate-breath delivery with a built-in regulator.
  • Offers 1-6 lpm flow equivalency settings to service a broad range of patients.
  • Delivers fixed pulse of oxygen within the first 200 milliseconds of inspiration.
  • Easy access to the battery compartment.
    • Description An All-In-One Conserver.

    Offers an average 5:1 increase in usage time at all settings.

    Allows the use of a standard cannula.

    The combination of the OXYMATIC conserver and lightweight cylinders offers ambulatory oxygen patients a superior alternative to liquid oxygen.

    Reliability backed by a 2-year warranty.

    NOTE: Each model has passed the ASTM PS 127-00 regulator ignition safety test.
    Info CHAD Therapeutics, Inc.
    Customer Service: (800) 423-8870
    Web site: http://www.chadtherapeutics.com

    Related medicine products :

    1. OXYMATIC® 401A Electronic Oxygen Conserver
    2. OXYMATIC® 411A Electronic Oxygen Conserver
    3. OXYMATIC® 411 Electronic Oxygen Conserver
    4. OXYMATIC® 411AF Electronic Oxygen Conserver
    5. SEQUOIA OXYMATIC® 302 Electronic Oxygen Conserver
    6. SEQUOIA OXYMATIC® 312 Electronic Oxygen Conserver
    7. OXYMATIC® 2400 Electronic Oxygen Conserver
    8. SEQUOIA OXYMATIC® 311 Electronic Oxygen Conserver
    9. MaximEyes Practice Management and Electronic Medical Records Software Solutions
    10. PRAXIS® Electronic Medical Records v. 2.19
    11. MaximEyes Optometric & Ophthalmology Software for Practice Management and Electronic Medical Records
    Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 8.0 mm and length 5 mm.
    Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 8.0 mm and length 7.5 mm.
    Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 8.0 mm and length 11 mm.
    Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 7.0 mm and length 8.7 mm.
    Medicine Products:
    (Date:5/16/2008)...r Seeks to Raise $38 Million for Life-threatening,...wire/ -- Walkers in nearly,every state will raise ...nd,18 -- by participating in GREAT STRIDES, the la... Foundation announced today., May is National Cys...,life-threatening genetic disease that causes fata...
    (Date:5/16/2008)...s is more unemployed politicians - and economists,... Although nearly all,voters place health care at t...oming federal budgetary crunch means none of the h...esidential candidates is likely to become,law anyt...Bill Frist., Jousting with Princeton University H...
    (Date:5/16/2008)...PRNewswire-USNewswire/ -- As tropical storms,conti...elta, survivors of,Cyclone Nargis are vulnerable t...rs still need assistance, as exposure to the foul ...gly dire situation., "The people living in these ... this disaster and get back on their feet," said D...
    (Date:5/16/2008)...., May 16 /PRNewswire-FirstCall/ -- Nationwide,Hea... the promotion of David,M. Boitano to Senior Vice ... made a tremendous contribution to NHP over the la...ment growth and diversification strategy,successes... accretive,investments for NHP, leveraging his vas...
    Breaking Medicine News(10 mins):Health News:GREAT STRIDES Walks for Cystic Fibrosis Slated for 47 States This Weekend 2Health News:Former Senate Majority Leader, Princeton Economist Joust on Future of Health Care 2Health News:Former Senate Majority Leader, Princeton Economist Joust on Future of Health Care 3Health News:Myanmar Cyclone Survivors Face New Challenges 2Health News:David M. Boitano Promoted to Senior Vice President 2
    ...has issued a temporary regulation on human organ t... organ trade, under control // and regulate transp...s regarding organ transplantation and donation wou...y in the best interest of the patients. The new r...
    ... that lifted up faces and brought cheer to the Chu... tabs for three types of obesity surgery, in case...ms. // But the catch is that, only surgeries perf...ons or the American Society of Bariatric Surgery w...
    ...irst to chair some healthy practices in classrooms...stand for hours a day. // This follows a study, wh... to significant weight loss, as against sitting wh.... According to researchers, children were capable ...
    ... in the May 1, 2006 issue of CANCER, a peer-review...t weight training// improves the quality of life o... cancer. A bi-weekly exercise regimen for six mont...tional condition of the patients. In the initial ...
    Other Medicine News:Health News:China Issues New Legislation To Ban Human Organ Trade 2Health News:Welcome to ‘Stand Only’ Classrooms That Exercise The Brain And The Bod 2
    (Date:5/15/2008)...d with a newly cleared device to identify the, li... are associated with complicatio...5 /- InfraReDx, Inc. today,announced ... Mich., have,successfully used its LipiScan(TM) Co...rdiac catheterization. This is the first patient i...
    (Date:5/15/2008)...May 15 /- Ergonex Pharma today,announ...ation (FDA) has,granted orphan drug designation to... hypertension (PAH). Terguride is currently being ...urope., "The FDA,s grant of orphan drug designati... our development program by offering regulatory,c...
    (Date:5/15/2008)...y 15 /- Tigris Pharmaceuticals,Inc. ...earch and,Development Agreement (CRADA) with the N...linical and preclinical development of AFP-464, an...P-464 is converted to,metabolites which bind coval...tosis., This is part of a four-year CRADA encompa...
    (Date:5/15/2008)...ains for an Antiplatelet Therapy that, Combined, w...tion of Plavix/Iscover and Aspirin, According ... Mass., May 15 /- Decision Resources,...firms for pharmaceutical and,healthcare issues, fi...,improvement in patient compared to Sanofi-Aventis...
    Breaking Medicine Technology:First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System 2First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System 3First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System 4Terguride Receives FDA Orphan Drug Designation for the Treatment of Pulmonary Arterial Hypertension 2Tigris Pharmaceuticals Signs CRADA with the National Cancer Institute 2Tigris Pharmaceuticals Signs CRADA with the National Cancer Institute 3Daiichi Sankyo/Eli Lilly's Effient and Astrazeneca's Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction 2Daiichi Sankyo/Eli Lilly's Effient and Astrazeneca's Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction 3Up for Debate This Week 3A National Service Mental Health Coverage and Consumer Product Safety 13227 1Up for Debate This Week 3A National Service Mental Health Coverage and Consumer Product Safety 13227 2Up for Debate This Week 3A National Service Mental Health Coverage and Consumer Product Safety 13227 3Publication in Clinical Cancer Research Confirms Ability of Peregrines Bavituximab to Target Tumor Blood Vessels with Excellent Specificity 3645 1Publication in Clinical Cancer Research Confirms Ability of Peregrines Bavituximab to Target Tumor Blood Vessels with Excellent Specificity 3645 2Publication in Clinical Cancer Research Confirms Ability of Peregrines Bavituximab to Target Tumor Blood Vessels with Excellent Specificity 3645 3Publication in Clinical Cancer Research Confirms Ability of Peregrines Bavituximab to Target Tumor Blood Vessels with Excellent Specificity 3645 4Publication in Clinical Cancer Research Confirms Ability of Peregrines Bavituximab to Target Tumor Blood Vessels with Excellent Specificity 3645 5Gentiva 28R 29 Health Services Completes Acquisition of Major Home Health Provider in CON State of Mississippi 13224 1Gentiva 28R 29 Health Services Completes Acquisition of Major Home Health Provider in CON State of Mississippi 13224 2Gentiva 28R 29 Health Services Completes Acquisition of Major Home Health Provider in CON State of Mississippi 13224 3Prime Healthcare Services Enters Into Network Wide Contract With Aetna Health Plans 13222 1Prime Healthcare Services Enters Into Network Wide Contract With Aetna Health Plans 13222 2
    ...RNewswire-FirstCall/ -- According to,study results...Association annual meeting, iloperidone, an invest...e a favorable akathisia,profile. Akathisia -- a de...s as an inability to sit still -- is a frequent si...e is being studied by Vanda,Pharmaceuticals Inc. ,...
    ...(BUSINESS WIRE) -- MGI PHARMA, INC.,(NASDAQ:MOGN),...nd,acute care, today announced the presentation of...Aquavan(R) (fospropofol,disodium) Injection in pat...y efficacy endpoint results, as well as safety dat...n Washington, D.C. by,Lawrence B. Cohen, MD, Depar...
    Other Medicine Technology:Antipsychotic Iloperidone Results Show Favorable Akathisia Profile 2Antipsychotic Iloperidone Results Show Favorable Akathisia Profile 3Antipsychotic Iloperidone Results Show Favorable Akathisia Profile 4Antipsychotic Iloperidone Results Show Favorable Akathisia Profile 5Aquavan (Fospropofol Disodium) Injection Data Presented at,Digestive Disease Week 2007 2Aquavan (Fospropofol Disodium) Injection Data Presented at,Digestive Disease Week 2007 3Aquavan (Fospropofol Disodium) Injection Data Presented at,Digestive Disease Week 2007 4Aquavan (Fospropofol Disodium) Injection Data Presented at,Digestive Disease Week 2007 5